AI Terminal
AlzChem Group AG
Regulatory Filings • Nov 17, 2021
33_rns_2021-11-17_27413d38-99c1-40fc-8196-eb54299e53a8.html
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Corporate | 17 November 2021 15:05
Alzchem Group AG: Increase of free float to 47.5%
DGAP-News: Alzchem Group AG / Key word(s): Miscellaneous
17.11.2021 / 15:05
The issuer is solely responsible for the content of this announcement.
Alzchem Group AG: Increase of free float to 47.5%
Trostberg, November 17, 2021 – The shareholder LIVIA Corporate Development SE (“LIVIA”) has informed Alzchem Group AG that it sold shares on November 16, 2021, thereby reducing its shareholding in the company to now 24.99% of the shares. The largest single shareholder has thus relinquished its constitutive blocking minority. In addition, LIVIA has stated that a further sale of shares in Alzchem Group AG is not intended.
Alzchem Group AG welcomes both the increase in the free float to 47.5% and LIVIA’s continued commitment to the company. It is convinced that both will have a positive effect on the perception of Alzchem shares on the capital market.
About Alzchem
Alzchem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. Alzchem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, Alzchem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Contact
T +49 8621 86-2888
F +49 8621 86-502888
17.11.2021 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Alzchem Group AG |
| Dr.-Albert-Frank-Str. 32 | |
| 83308 Trostberg | |
| Germany | |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | [email protected] |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 1249886 |
| End of News | DGAP News Service |